Ontology highlight
ABSTRACT:
SUBMITTER: Miyazaki K
PROVIDER: S-EPMC6144206 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
Journal of clinical and experimental hematopathology : JCEH 20160101 2
Diffuse large B-cell lymphoma (DLBCL) comprises a heterogeneous group with pathophysiological, genetic and clinical features. Many patients can be cured with R-CHOP therapy, which is the current standard regimen. Despite recent progress in improving patient survival, the 40% survival of DLBCL patients remains poor. Therefore, the most important issue for patients with DLBCL remains the development of a new front-line therapy. Several studies have reported that intensified chemotherapy with dose- ...[more]